Our results reinforce the prognostic value of high circulating levels of PlGF for poor outcomes in various cancer types previously reported (e.g., in renal cell carcinoma and oral squamous cell carcinoma [14, 15]). The gene discussed is PGF; the disease is renal cell carcinoma.